Publicaciones en las que colabora con MARÍA LUISA GÓMEZ-LUS CENTELLES (25)

2024

  1. Peri-Implant Microbial Signature Shifts in Titanium, Zirconia and Ceria-Stabilized Zirconia Reinforced with Alumina Sites Subjected to Experimental Peri-Implantitis: A Preclinical Study in Dogs

    Antibiotics, Vol. 13, Núm. 8

  2. Perspectivas Educativas en Microbiología: Análisis del Impacto de las Prácticas Virtuales vs las Prácticas Presenciales en Alumnos del Grado de Podología

    Revista Española de Educación Médica, Vol. 5, Núm. 2, pp. 112-123

2023

  1. Do face masks increase the rate of the Staphylococcus aureus nasal carriers?

    Revista Espanola de Quimioterapia

  2. Effect on the reduction of bacterial load after surgical hand antisepsis with triclosan 0.5% compared to triclosan 0.5% followed by 70% alcoholic solution

    Infection Control and Hospital Epidemiology, Vol. 44, Núm. 3, pp. 517-519

2021

  1. Comparing rubbing and scrubbing surgical hand antisepsis with propan-1-ol 60% in accordance with European regulation UNE-EN 12791:2016+A1:2018

    Infection Control and Hospital Epidemiology, Vol. 42, Núm. 11, pp. 1382-1384

2018

  1. Prevalence of Staphylococcus spp. nasal colonization among doctors of podiatric medicine and associated risk factors in Spain

    Antimicrobial Resistance and Infection Control, Vol. 7, Núm. 1

2017

  1. ¿Está indicada la prescripción de antibióticos en la extracción del tercer molar retenido?: Estudio comparativo entre patrones de prescripción

    Revista Espanola de Quimioterapia, Vol. 30, Núm. 1, pp. 34-39

2016

  1. Bacterial translocation affects intracellular neuroinflammatory pathways in a depression-like model in rats

    Neuropharmacology, Vol. 103, pp. 122-133

2014

  1. Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress

    Journal of Neuroinflammation, Vol. 11

2013

  1. Influence of the MBC/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum and soft tissue interstitial fluid concentrations reported in diabetic patients

    Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 10, pp. 2291-2295

2011

  1. Evolving architectural patterns in microbial colonies development

    Microscopy Research and Technique, Vol. 74, Núm. 10, pp. 925-930

2010

  1. Impacto del consumo de antibióticos de uso tópico oftalmológico

    Revista Espanola de Quimioterapia, Vol. 23, Núm. 4, pp. 201-205

2009

  1. Colonial architecture and growth dynamics of Staphylococcus aureus resistant to methicillin

    Revista Espanola de Quimioterapia, Vol. 22, Núm. 4, pp. 224-227

  2. Colonic bacterial translocation as a possible factor in stress-worsening experimental stroke outcome

    American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 296, Núm. 4

2007

  1. Pharmacodynamics of simulated total versus free-drug serum concentrations of a low versus a high protein bound third-generation oral cephalosporin (cefpodoxime versus cefditoren) against Streptococcus pneumoniae

    Journal of Chemotherapy, Vol. 19, Núm. 3, pp. 288-294

  2. The Role of PPARγ on Restoration of Colonic Homeostasis After Experimental Stress-Induced Inflammation and Dysfunction

    Gastroenterology, Vol. 132, Núm. 5, pp. 1791-1803

2006

  1. Influencia del desplazamiento de la unión a proteínas por ibuprofeno en la actividad de una cefalosporina de tercera generación frente a Streptococcus pneumoniae

    Revista Espanola de Quimioterapia, Vol. 19, Núm. 4, pp. 332-336

2005

  1. Is there a pharmacodynamic need for the use of continuous versus intermittent infusion with ceftazidime against Pseudomonas aeruginosa? An in vitro pharmacodynamic model

    Journal of Antimicrobial Chemotherapy, Vol. 55, Núm. 2, pp. 209-213

2004

  1. In vitro combined effect of co-amoxiclav concentrations achievable in serum after a 2000/125 mg oral dose, and polymorphonuclear neutrophils against strains of Streptococcus pneumoniae exhibiting decreased susceptibility to amoxicillin

    International Journal of Antimicrobial Agents, Vol. 24, Núm. 1, pp. 79-82

2002

  1. Ex vivo serum activity (killing rates) after gemifloxacin 320 mg versus trovafloxacin 200 mg single doses against ciprofloxacin-susceptible and -resistant Streptococcus pneumoniae [1]

    International Journal of Antimicrobial Agents